While the world is no longer living in a COVID-19 pandemic crisis mode, Health Minister, Dr Joe Phaahla, has warned BRICS leaders that they cannot afford to let their guard down.
“This virus will still unfortunately continue to cause havoc in our population and in our economy,” he cautioned on Friday.
“We just need to make sure that we are tracking the virus because it will continue to evolve and pose risk in our societies.”
However, he said he was hopeful that the leaders now have the tools and the political will in place to ensure that future waves do not result in more severe diseases and deaths.
Phaahla, together with Health Ministers from Brazil, Russia, India, and China were speaking at the adoption of the declaration of the 13th BRICS Health Ministers Meeting.
Today marked the last day of BRICS health events currently underway at the Durban International Convention Centre in the run-up to the 15th BRICS Summit in August 2023.
The 13th BRICS Health Ministers Meeting was taking place under the ‘Bridging the Gap on Sustainable Health on the Road to Universal Health Coverage 2023’ theme.
The Minister said the bloc partnership has a significant role to play in surveillance, preparedness, and developing health mechanisms to confront pandemics.
Universal health coverage (UHC)
He said over the last decade, the BRICS countries have committed to substantial health-system reforms designed to improve equity in service use, quality, and financial protection, with the ultimate goal of achieving UHC.
Last month, the National Assembly passed the National Health Insurance (NHI) Bill paving the way for universal healthcare, bringing it a step closer to being signed into law and being rolled out.
“This is one of the most revolutionary bills ever passed by the National Assembly since the dawn of our democracy in 1994,” he told delegates.
UHC, he said is undoubtedly the cornerstone to achieving Sustainable Development Goal 3, on good health and well-being.
“We have an opportunity to make our voices heard as BRICS countries building on our hard negotiated and agreed goals towards universal health agenda.”
He believes that the BRICS nations are a force to be reckoned with, as they carry a great number of the world's population of underprivileged societies.
“So we should leverage our involvement in the G20 to push the global health agenda and related areas for ensuring global health security.”
He also acknowledged that there is still a lot to be done to ensure access and equity to safe and essential medical products for people, especially in developing countries.
Vaccines
Phaahla also touched on the equitable distribution of vaccines and expeditious vaccination, to fill the immunisation gap globally.
“We should, therefore, remain focused on discussions on the importance of the World Trade Organisation on relevant intellectual property waiver proposals, as well as capacity building and strengthening local production of vaccines and other health tools, especially in developing countries,” he stressed, adding that mNRA hubs should be supported.
Phaahla said the leaders have also agreed that they should jointly take proactive and effective measures to prevent and reduce the risk of cross-border transmission of infectious diseases and contribute to improving global health.
Public health emergencies
This year, he said they also added a BRICS Network of Public Health Emergency Centres (PHEOC), serving as nerve centres for preparation and response to public health emergencies.
“This is especially critical as we reflect on the COVID-19 pandemic response and aim to build back better for future outbreaks and pandemics.
“The effective coordination and improved control of outbreaks as evidenced by shorter times from detection to response that a functional PHEOC is valuable in the prompt containment of infectious disease outbreaks in all countries.”
He said the medicines regulatory authorities were also ready to sign a Memorandum of Understanding (MoU) for cooperation.
He said this was a significant step towards realising the objective to work together in the field of medical products regulation.
This, according to Phaahla, will also enable the nations to share regulatory experience and best practices.
It will also enable them to exchange experts for capacity building as well as facilitate the regulatory landscape to promote research and development and adaptation through technology transfer of innovative medical products.
These include drugs, vaccines, medical technologies, and anti-microbial resistance. – SAnews.gov.za
